Notably, significant differences were observed across races between CRC and non-CRC GI malignancies (p < 0.001), with 11% of those with a non-CRC GI malignancy being black or African American, versus only 6.4% of those with BRAF-altered CRC. The gene discussed is BRAF; the disease is colorectal carcinoma.